Chlordiazepoxide hydrochloride and clidinium bromide
Chlordiazepoxide Hydrochloride and Clidinium Bromide is a prescription medication combining a benzodiazepine and an anticholinergic to help manage symptoms of irritable bowel syndrome, such as abdominal pain and spasms. It comes as oral capsules (5 mg chlordiazepoxide and 2.5 mg clidinium) and is a controlled substance (Schedule CIV). Manufactured by Alembic Pharmaceuticals Inc. This information was generated using AI and is provided for informational and research purposes only.
Resources
1 resource available
-
Chlordiazepoxide hydrochloride and clidinium bromide
TEXT/HTML
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Chlordiazepoxide Hydrochloride and Clidinium Bromide is a prescription medication combining a benzodiazepine and an anticholinergic to help manage symptoms of irritable bowel syndrome, such as abdominal pain and spasms. It comes as oral capsules (5 mg chlordiazepoxide and 2.5 mg clidinium) and is a controlled substance (Schedule CIV). Manufactured by Alembic Pharmaceuticals Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Chlordiazepoxide hydrochloride and clidinium bromide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Chlordiazepoxide hydrochloride and clidinium bromide — ANDA 213530 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213530"
}
]
|
| identifier | ANDA213530 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"health-care",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Chlordiazepoxide hydrochloride and clidinium bromide |
